Learn how the Bridge Program applies to NYCE PPO, Large Group, and ASO plan members in 2026.
Search
Popular Tasks
Biosimilars: Interchangeable Products May Increase Patient Access
06/21/2022
Depending on state pharmacy laws, you may substitute an interchangeable biosimilar product at the pharmacy, much like substituting a generic for a brand-name drug. This helps increase patient access to biologics and may reduce patient costs. Learn more about Interchangeable Biological Products from the FDA. Bookmark FDA’s Biosimilars web page and materials for health care providers and patients.
Additional FDA resources you may find helpful: